Osiris Therapeutics (OSIR) Posts Narrower than Expected Q2 Loss of 13c/Share
Tweet
Share
E-mailGet Alerts OSIR Hot Sheet
Price: $18.99 --0%
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Diluted earnings per share (in dollars per share): -0.02
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Osiris Therapeutics (NASDAQ: OSIR) reported Q2 EPS of ($0.13), $0.02 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $1.63 million versus the consensus estimate of $1.57 million.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
For earnings history and earnings-related data on Osiris Therapeutics (OSIR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- SPAR Group (SGRP) Reports Q2 EPS of $0.04
- NextPlat Corp (NXPL) Reports Q2 Loss of $0.05
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
